Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,826 | -6,048 | -4,916 | -2,483 | -9,289 |
| Accounts payable and accrued liabilities | 31 | 5 | 14 | 53 | -23 |
| Other Working Capital | 907 | -128 | -328 | -574 | 663 |
| Other Operating Activity | 538 | 388 | 225 | 62 | 442 |
| Operating Cash Flow | $-8,350 | $-5,783 | $-5,005 | $-2,942 | $-8,207 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -481 | -481 | -481 | -481 | -12,173 |
| Sale Of Investment | 8,250 | 7,750 | 3,500 | 1,750 | 15,680 |
| Investing Cash Flow | $7,769 | $7,269 | $3,019 | $1,269 | $3,507 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 112 | N/A | 55 | 55 | 567 |
| Other Financing Activity | 0 | 55 | 0 | 0 | 0 |
| Financing Cash Flow | $112 | $55 | $55 | $55 | $567 |
| Exchange Rate Effect | -8 | 1 | -3 | -2 | 60 |
| Beginning Cash Position | 2,815 | 2,815 | 2,815 | 2,815 | 6,888 |
| End Cash Position | 2,338 | 4,357 | 881 | 1,195 | 2,815 |
| Net Cash Flow | $-477 | $1,542 | $-1,934 | $-1,620 | $-4,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,350 | -5,783 | -5,005 | -2,942 | -8,207 |
| Free Cash Flow | -8,350 | -5,783 | -5,005 | -2,942 | -8,207 |